financial results
Interpace Biosciences Posts 6 Percent Revenue Increase in Q1
The company said that it experienced improved reimbursement rates and clinical services volume for its thyroid cancer tests compared to Q1 of last year.
Accelerate Diagnostics Q1 Revenues Climb 20 Percent
The company added two contracted instruments and brought five instruments online during the quarter.
Sema4 Q1 Revenues Decline 16 Percent
The firm, which acquired GeneDx last month, recently cut its workforce by 10 percent as it charts a path to profitability.
SomaLogic Q1 Revenues Grow 22 Percent
The Boulder, Colorado-based protein analysis company missed the consensus Wall Street revenue estimate but beat it on the bottom line.
Lucira Health Hits $90.5M in Q1 Revenues on Back of COVID-19 Test Sales
The firm also submitted its combination COVID-19 and influenza test to the US Food and Drug Administration for Emergency Use Authorization.
May 12, 2022
LumiraDx Q1 Revenues up 18 Percent
May 11, 2022
Exagen Q1 Revenues Drop 2 Percent
May 10, 2022
Sophia Genetics Q1 Revenues Increase 21 Percent
May 10, 2022
Quanterix Q1 Revenues up 9 Percent
May 9, 2022
Castle Biosciences Q1 Revenues Grow 18 Percent
May 6, 2022
Chembio Q1 Revenues More Than Double
May 5, 2022
CareDx Q1 Revenues up 18 Percent
May 5, 2022